Skip to main content
. 2022 Jul 22;9:903412. doi: 10.3389/fcvm.2022.903412

TABLE 2.

Results of clinical laboratory test.

Characteristics HC T2DM T2DM-CHD P1 value (HC vs T2DM) P2 value (HC vs T2DM-CHD) P3 value (T2DM vs T2DM-CHD)
Blood biochemistry
TC (mmol/L) 4.56 ± 0.94 4.73 ± 1.06 3.93 ± 1.07 0.134 7.58E-07&& 6.00E-09**
HDL-C (mmol/L) 1.33 ± 0.34 1.25 ± 0.40 1.09 ± 0.29 0.010 3.10E-09&& 0.001**
LDL-C (mmol/L) 2.62 ± 0.72 2.82 ± 0.84 2.20 ± 0.84 0.028 1.65E-05&& 1.06E-08**
TG (mmol/L) 1.32 ± 0.69 1.70 ± 1.17 1.68 ± 1.20 0.005 0.025& 0.618
Glucose (mmol/L) 5.24 ± 2.17 8.50 ± 3.68 9.51 ± 4.49 1.15E-22 9.22E-26&& 0.111
Uric (μmol/L) 303 ± 71 315 ± 78 334 ± 91 0.212 0.006&& 0.120
DBIL (μmol/L) 3.47 ± 1.86 3.23 ± 2.32 4.03 ± 2.10 0.163 0.0342& 7.00E-04**
IBIL (μmol/L) 9.44 ± 4.20 10.3 ± 5.80 8.74 ± 4.39 0.493 0.1090 0.041*
TBA (μmol/L) 4.44 ± 3.68 4.06 ± 3.78 4.10 ± 4.28 0.262 0.1338 0.616
Creatinine (μmol/L) 70.6 ± 16.8 70.2 ± 16.5 77.7 ± 21.9 0.514 0.0248& 0.008**
HsCRP (mg/L) NA 2.93 ± 3.27 4.24 ± 3.82 0.001**
AST (U/L) 24.1 ± 10.5 28.0 ± 71.3 69.6 ± 111.8 0.006 0.057 2.10E-04**
ALT (U/L) 21.6 ± 11.1 25.4 ± 25.3 32.8 ± 35 0.579 9.09E-05&& 0.002**
CK (U/L) 98.6 ± 45.1 90.7 ± 51.0 442 ± 877 0.013 0.240 0.005**
MMB (ng/L) NA NA 32.7 ± 74.3
CTNI (ng/L) NA NA 16.3 ± 37.3
LDH (U/L) 172 ± 29 158 ± 40 282 ± 258 2.88E-05 0.005&& 3.08E-08**
HBDH (U/L) 140 ± 23 134 ± 27 252 ± 252 0.030 1.37E-04&& 3.93E-07**
ALP (U/L) 82.7 ± 23.7 91.5 ± 25.1 86.6 ± 26.5 7.06E-04 0.143 0.067
GGT (U/L) 30.1 ± 26.2 40.2 ± 52.0 36.8 ± 31.4 0.083 0.007&& 0.582
HCY (μmol/L) NA 13.5 ± 4.8 16.9 ± 6.3 1.57E-07**
NT-proBNP (pg/mL) NA NA 1,146 ± 2,098
HbA1c (%) NA 9.85 ± 2.23 8 ± 1.61 3.55E-10**
Blood pressure
SBP (mmHg) 128 ± 16 146 ± 26 158 ± 30 1.97E-10 9.00E-18&& 2.56E-04**
DBP (mmHg) 78.4 ± 10.9 83.9 ± 15.3 90.7 ± 20.1 3.52E-04 1.96E-08&& 0.006**
Erythrocyte function
RBC (× 1012/L) 4.58 ± 0.47 4.47 ± 0.48 4.36 ± 0.54 0.094 0.001&& 0.071
HGB (g/L) 142 ± 13 138 ± 16 140 ± 92 0.018 7.26E-06&& 0.030*
HCT (%) 41.4 ± 3.5 39.6 ± 4.2 38.6 ± 4.6 2.38E-04 1.16E-07&& 0.068
MCV (fl) 90.7 ± 4.6 88.8 ± 5.2 88.7 ± 4.8 4.05E-04 0.002&& 0.773
MCH (pg) 31.1 ± 2.1 30.8 ± 2.2 30.3 ± 2.1 0.443 0.015& 0.077
MCHC (g/L) 343 ± 11 346 ± 12 343 ± 12 0.003 0.990 0.005**
RDW-CV (%) 12.9 ± 0.9 12.8 ± 1.0 13.1 ± 1.3 0.090 0.036& 3.56E-04**
Blood platelet
PLT (× 109/L) 213 ± 56 219 ± 53 207 ± 49 0.239 0.483 0.043*
PDW (fl) 12.6 ± 2.2 12.6 ± 1.8 12.4 ± 1.7 0.494 0.833 0.352
MPV (fl) 10.5 ± 1 10.5 ± 0.9 10.6 ± 0.9 0.605 0.197 0.371
P-LCR (%) 28.8 ± 8.2 29.1 ± 7.1 29.6 ± 7.1 0.534 0.254 0.547
Coagulation function
PT (s) 11.3 ± 0.8 11.2 ± 0.8 11.5 ± 1.9 0.094 0.837 0.228
PA (%) 93.7 ± 6.3 97.8 ± 8 93.9 ± 10.6 4.03E-06 0.707 4.36E-04**
PR 1.00 ± 0.06 0.98 ± 0.07 1.01 ± 0.15 0.001 0.461 0.028*
INR 0.99 ± 0.05 0.96 ± 0.06 0.99 ± 0.16 1.45E-05 0.573 0.001**
APTT (s) 28.6 ± 3.5 27.6 ± 3.9 28.8 ± 5.6 0.020 0.457 0.247
FBG (mg/dL) 263 ± 51 292 ± 72 296 ± 75 1.82E-04 9.47E-05&& 0.712
TT (s) 19.1 ± 1.5 18.7 ± 1.7 20.0 ± 9.3 0.004 0.354 0.094
D-DIMER (mg/L) NA 0.36 ± 0.50 0.42 ± 0.57 0.016*
Thyroid Function
FT3 (pg/mL) NA 2.61 ± 0.43 2.58 ± 0.75 0.124
FT4 (ng/dl) NA 1.05 ± 0.14 1.06 ± 0.17 0.571
STSH (uIU/ml) NA 1.91 ± 1.97 1.66 ± 1.62 0.079

Data was presented as mean ± SD, unless otherwise specified. P values were calculated by hypothesis testing. Data distribution was assessed by the Shapiro–Wilk test. Bilateral student’s t-test was used for normally distributed data. While the Mann–Whitney U test was used for non-parametric data. (&, *), P < 0.05; (&&, **), P < 0.01.